Abstract
Hereditary dentin defects can be categorized as a syndromic form predominantly related to osteogenesis imperfecta (OI) or isolated forms without other non-oral phenotypes. Mutations in the gene encoding dentin sialophosphoprotein (DSPP) have been identified to cause dentinogenesis imperfecta (DGI) Types II and III and dentin dysplasia (DD) Type II. While DGI Type I is an OI-related syndromic phenotype caused mostly by monoallelic mutations in the genes encoding collagen type I alpha 1 chain (COL1A1) and collagen type I alpha 2 chain (COL1A2). In this study, we recruited families with non-syndromic dentin defects and performed candidate gene sequencing for DSPP exons and exon/intron boundaries. Three unrelated Korean families were further analyzed by whole-exome sequencing due to the lack of the DSPP mutation, and heterozygous COL1A2 mutations were identified: c.3233G>A, p.(Gly1078Asp) in Family 1 and c.1171G>A, p.(Gly391Ser) in Family 2 and 3. Haplotype analysis revealed different disease alleles in Families 2 and 3, suggesting a mutational hotspot. We suggest expanding the molecular genetic etiology to include COL1A2 for isolated dentin defects in addition to DSPP.
Keywords: hereditary, mutational hotspot, dentinogenesis imperfecta, isolated dentin defect, tooth, discoloration, COL1A2
1. Introduction
Dentin is one of the major components comprising the teeth, and the crown part is covered by dental enamel, the hardest tissue in the human body. The root part inside the alveolar bone is covered by cementum, a thin bonelike tissue [1]. Dentin has similar mechanical properties with bone but has unique microstructures, parallel dentinal tubules from the dentin-enamel junction all the way to the pulp tissue [2]. Each dentinal tubule is filled with a long process of differentiated pulp cells, odontoblasts. This unique dentinal structure is believed to enable supporting extremely hard but brittle enamel and also providing a mechanosensory function to protect against noxious stimuli [3].
Hereditary dentin defects can occur with or without other syndromic phenotypes, like many other genetic diseases. Shields’ classification system consists of five types with two major categories: three types of dentinogenesis imperfecta (DGI) and two types of dentin dysplasia (DD) [4]. Among them, the DGI Type I (OMIM #166200) is the only syndromic form, a dental phenotype related to brittle bone diseases, osteogenesis imperfecta (OI). Some but not all OI patients exhibit variously discolored (brown to grey discoloration with opalescent hue) dentition and some characteristic tooth phenotypes, including bulbous crown, delayed dentin development or accelerated pulp chamber obliteration. The penetrance is not complete, and the expressivity is also variable among the same affected family members and even depends on the teeth in the dentition of an individual [5].
Mutations in the gene encoding dentin sialophosphoprotein (DSPP), the most abundant non-collagenous protein in the dentin matrix, have been identified to cause DGI Types II (OMIM #125490) [6,7], III (OMIM #125500) [8,9] and DD Type II (OMIM #125420) [10]. Now, these subtypes are recognized as allelic heterogeneity; therefore, there are some overlapping phenotypes because they are on a wide spectrum of the disorders depending on the severity of the mutation [11]. However, there is no other candidate gene except DSPP causing isolated DGI Types II and III and DD Type II.
Therefore, if a patient has a dental phenotype of DGI Types II or III or DD Type II without other non-oral symptoms, especially OI-related symptoms, the primary candidate gene to suspect is DSPP. Candidate gene sequencing of DSPP is not easy, especially for the last exon 5, which encodes part of the dentin sialoprotein (DSP) and the entire dentin phosphoprotein (DPP). Allele-specific cloning is necessary for the DPP-encoding region because it contains an ~2.4 kb repeat domain including an ~1.2 kb 3′ hypervariable repeat region [9]. Whole-exome sequencing seems to be not enough to get sufficient coverage and alignments in this region due to the extreme repeat.
In this study, we performed next-generation sequencing (NGS) analysis to identify the disease-causing mutations in three Korean families with an isolated hereditary dentin defect, whose DSPP gene candidate sequencing resulted in no disease-causing mutation. Genetic analysis identified mutations in the gene encoding collagen type I alpha 2 chain (COL1A2), a gene involved in OI pathogenesis.
2. Materials and Methods
2.1. Human Subject Enrollment
The study protocol and consent form were reviewed and approved by the Institutional Review Board of Seoul National University Dental Hospital. The nature of the study was explained, and informed consent was obtained from all participating individuals following the principles in the Declaration of Helsinki. Three unrelated nonconsanguineous Korean families were selected for this study.
2.2. Genomic DNA Isolation
A total of 3~4 mL of peripheral blood samples were collected, and genomic DNA was isolated by a conventional method with the NucleoSpin Blood L kit (Macherey-Nagel GmbH & Co., Düren, Germany) according to the manufacturer’s instructions. The quantity and quality of the DNA were quantitated by spectrophotometry measured by the OD260/OD280 ratio.
2.3. Candidate Gene Sequencing of the DSPP Gene
As a candidate gene approach, exons and exon-intron boundaries were amplified and sequenced as described before [12,13]. Briefly, PCR amplification and Sanger sequencing were performed for Exons 1, 2, 3 and 4 and the N-terminal end of Exon 5. Most of Exon 5, which is a highly repetitive and long DPP region, was amplified and cloned to sequence individual alleles. Multiple clones were sequenced and analyzed using Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/ (accessed on 16 July 2019)).
2.4. Whole-Exome Sequencing
Candidate gene sequencing of the DSPP gene did not reveal a disease-causing variant. Whole-exome sequencing was performed for the selected individuals (III:2 in Family 1, III:2 in Family 2, and IV:2 in Family 3). Exomes were captured with the Agilent SureSelectXT Human All Exon V6-Post Target Enrichment System, and 101-bp paired-end sequencing reads were generated with the NovaSeq sequencing platform (Macrogen, Seoul, Korea) (Table S1). A series of bioinformatic analyses was performed as previously described [14]. Briefly, sequencing reads were aligned to the reference human genome assembly hg38 using the Burrows-Wheeler Aligner alignment program, and then, the Samtools and Genome Analysis Tool Kit were used to get a list of small indels and single nucleotide changes [15,16,17]. Annotation of the variants was performed with Annovar against the single nucleotide polymorphism database (dbSNP) build 150 [18], and variants were filtered with the cut-off value of a minor allele frequency (MAF) of 0.01. The COL1A2 mutations were confirmed by Sanger sequencing.
2.5. Haplotype Construction
Haplotypes of the affected individuals (III:2 in Family 2 and IV:2 in Family 3) were constructed using nearby whole-exome sequencing data to investigate whether they share the same disease allele from a common ancestor.
3. Results
3.1. Family 1
The proband was a four-year-old second son in a nonconsanguineous Korean family (Figure 1). He presented with complaints of excessive attrition and class III malocclusion. His deciduous dentition had a mild brown discoloration, especially in the anterior teeth. Severe attritions occurred in several teeth: the primary maxillary lateral incisors, primary maxillary canines, and primary maxillary first molars (Figure S1). Erupting mandibular central incisors also had a mild brown discoloration. His older brother also had a similar dental phenotype. His permanent anterior teeth exhibited minimal yellowish discoloration. Panoramic radiographs showed that the pulp chambers of the primary teeth were almost completely obliterated. The mother also had mild brown discoloration. Pulp chamber obliteration was seen in a panoramic radiograph. The grandfather and uncle of the proband were reported to have a similar dental phenotype. The family had no OI-related symptoms including fracture, articular pain, joint laxity, blue sclera, hearing problem, and hypodontia, and there was no other remarkable past medical history.
The filtered variants with the cut-off value of a MAF of 0.01 were further processed by removing variants with synonymous changes and non-frameshift deletions or insertions. After further manual checkup with Alamut Visual program (SOPHiA Genetics, Lausanne, Switzerland), whole-exome sequencing data analysis of the proband resulted in several candidate variants (Table S2). The candidate variant lists of Family 1 and Family 2 (Table S3) were compared to find a common disease-causing gene and resulted in COL1A2 as a candidate gene. The mutation was a missense mutation caused by a transitional change of a glycine to an alanine (NM_000089.4:c.3233G>A) in Exon 48. This mutation would cause a change of glycine, which is a completely conserved amino acid in the helical domain, to aspartic acid at codon position 1078 (NP_000080.2:p.(Gly1078Asp)). Sanger sequencing confirmed the mutation in all participating affected individuals (Table S4, Figure S2). As mentioned above, the glycine at this position is completely conserved among the homologs of vertebrates (Figure S3). This mutation was predicted to be ‘possibly damaging’ by PolyPhen2 (probability of 1), ‘disease causing’ by mutation taster (with a score of 1.000) and combined annotation dependent depletion (CADD) resulted in a high (25.1) prediction value (Table S5). Interestingly, this mutation was listed in the dbSNP (rs72659332) without the allele frequency and was not listed in a public database, the genome aggregation database (GnomAD).
3.2. Family 2
The proband was a three year ten month old daughter from a nonconsanguineous family and presented with a complaint of discolored teeth (Figure 2). She had a generalized brown discoloration in all deciduous dentition. Some teeth were not evenly discolored with some whitish areas. The mother also had a mild to moderate brown discoloration in the mandibular anterior teeth; however, the discoloration was minimal, if any, in the maxillary anterior teeth. The grandmother and great-grandfather were reported to have a similar dental phenotype. This family also had no OI-related symptoms listed above, and there was no other remarkable medical history.
Mutational screening of this family with Family 1 revealed a missense mutation in COL1A2, changing a conserved glycine to serine at codon 391 (NP_000080.2:p.(Gly391Ser)) by a transitional change of glycine to an alanine (NM_000089.4:c.1171G>A) in Exon 21. The mutation was confirmed by Sanger sequencing (Table S4), and the conservation among the homologs of vertebrates was also verified (Figure S3). This mutation was predicted as pathogenic by PolyPhen2 (possibly damaging; probability of 1), mutation taster (disease causing; a score of 1.000), and CADD (prediction value 33) (Table S5). This mutation was listed in the dbSNP (rs67707918); however, the allele frequency was not known and not listed in GnomAD.
3.3. Family 3
The proband was a four year eight month old second son from a nonconsanguineous family (Figure 3). He was referred from a local dental clinic with a chief complaint of discolored and brittle teeth. Several mandibular primary molars fractured in combination with dental caries. The mother had mild discoloration and fractures in addition to the attrition in the mandibular anterior teeth and some premolars. An untreated mandibular left second molar exhibited exacerbated attrition and destruction. The grandmother and great-grandmother were reported to have a similar dental phenotype with mild discoloration; however, they did not have tooth fractures or severe attrition. There were no OI-related symptoms listed above, and there was no other remarkable medical history in this family as well.
Interestingly, whole-exome sequencing data analysis revealed the same mutation with Family 2. The mutation in the affected family members was confirmed by Sanger sequencing (Figure S2). To determine whether this mutation is from a common ancestor, haplotype analysis was performed with nearby SNP sequences from the whole-exome sequencing. Comparison of the haplotypes between the affected individuals (III:2 of Family 2 and IV:2 of Family 3) showed that all the alleles are different indicating the disease-alleles are not identical by descent (Figure 4).
4. Discussion
The classic classification system of OI was proposed by Sillence et al. in 1979 and was based on clinical characteristics and inheritance pattern [19]: Type I is a nondeforming OI with little or no deformity, blue sclerae, hearing loss in 50% of families, and without (Subtype A) or with (Subtype B) DGI; Type II is perinatally lethal; Type III is progressive deforming, and Type IV is a moderate form, more severe than Type I but milder than Types II and III. With the advancement of genetic studies identifying more than 16 genes other than COL1A1 or COL1A2, a modified classification was proposed to include genetic the etiology [20]. However, the most common mutations involved in OI are substitutions of glycine in the triple helix domain of Type I collagen [21].
The mutations identified in this study are listed in the dbSNP database build 130, which was updated on 30 April 2009. Both mutations were listed as unpublished data in the Supplementary Material from a study from a consortium of OI mutations in the helical domain of Type I collagen [22]: The p.(Gly1078Asp) was listed twice with the Type I and Type IV non-lethal phenotypes, and the p.(Gly391Ser) was listed with a Type III phenotype. Later on, the p.(Gly391Ser) was listed in a familial case with a Type IV phenotype in an OI-related paper [23]. These phenotypic variations could be a result of different genetic backgrounds and/or other genetic modifiers.
An interesting case with familial tooth agenesis and spontaneous DGI was reported to be caused by the maternal PAX9 (c.43T>A, p.(Phe15Ile)) and de novo COL1A2 (c.1171G>A, p.(Gly391Ser)) mutations, respectively [24]. The proband was a five-year-old boy of European descent and had no systemic signs and history of bone fracture. Bone radiographs showed no evidence supporting OI and were within normal limits. Recently, the same mutation was identified as an inherited one in a three-generation Thai family [25]. The affected individuals had DGI Type II phenotypes, such as discoloration, bulbous crowns, and dental pulp obliteration. However, they had normal facial features and hearing without blue sclerae, with no evidence of brittle bones and hyperflexible joints. The dental phenotype was variable among family members, and even within the same individual, some teeth (especially the maxillary anterior teeth and newly erupting mandibular anterior teeth) were unremarkable.
In this study, the same mutation was identified in two unrelated Korean families without OI-phenotype. Haplotype analysis revealed they did not share the same disease allele from a common ancestor. Taken together with a de novo occurrence in a European descent and a familial case in a Thai family, it is strongly suggested that this mutation is a mutational hotspot in COL1A2, related to the non-syndromic DGI.
When the OI classification was proposed, the genetic etiology was not known, and Types II and III were suspected to be autosomal recessive for some cases [19]. However, more recent reports have shown that these severe phenotypes are caused by a dominant-negative effect of the dominant COL1A1 or COL1A2 mutations, while true autosomal recessive inheritance is very rare [26]. The genotype-phenotype relationship revealed that the mutations in COL1A2 are milder, predominantly nonlethal compared to the mutations in COL1A1 [21].
Recently, a homozygous COL1A2 mutation [c.604G>A, p.(Gly202Ser)] was reported in a Greek consanguineous family [27]. The proband and another affected sibling had severe skeletal fragility, but the mutation carriers were free from any OI features, even without DGI. Another homozygous COL1A2 mutation [c.1009G>A, p.(Gly337Ser)] was identified in a Thai consanguineous family [28]. The proband, a 17-year-old woman, was diagnosed with OI Type III and DGI; however, her heterozygous carrier parents had only DGI.
It seems clear that mild and weak mutations in COL1A2 can cause DGI as an isolated form, without OI-related symptoms. They share common phenotypic characteristics with variable expressivity depending on the teeth, unlike the DGI Types II and III phenotypes. In general, the severity of dentin defects caused by these mild COL1A2 mutations seems to be worse than the DD Type II but not as severe as DGI Type II.
In conclusion, we recruited three non-syndromic Korean families with hereditary dentin defects, and a mutational study including candidate sequencing of DSPP and whole-exome sequencing revealed heterozygous mutations in COL1A2. Therefore, we suggest including COL1A2 as a candidate gene for isolated dentin defects in addition to DSPP.
Acknowledgments
We are grateful to all family members who participated in this study.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/jpm11060526/s1, Table S1: statistics for exome sequencing; Table S2: filtered sequence variants of Family 1; Table S3: filtered sequence variants of Family 2; Table S4: COL1A2 PCR primers; Table S5: variants identified in COL1A2 gene (GenBank: NM_000089.4); Figure S1: clinical photos and panoramic radiograph of Family 1; Figure S2: sequencing chromatograms; Figure S3: sequence alignments of vertebrate orthologs.
Author Contributions
Y.L. and Y.J.K. contributed to performing the experiments, data analysis, interpretation and drafting of the paper. H.-K.H., J.-C.L. and J.-W.K. contributed to diagnosis and recruitment of the family members, and critically revised the paper. Z.H.L. and J.-W.K. contributed to designing and performing the research, interpretation and molecular diagnosis, drafted the paper, and critically revised the paper. All authors have read and agreed to the published version of the manuscript.
Funding
This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (NRF-2018R1A5A2024418 and NRF-2020R1A2C2100543).
Institutional Review Board Statement
The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of the Seoul National University Dental Hospital.
Informed Consent Statement
Informed consent was obtained from all individual participants included in the study.
Data Availability Statement
The data presented in this study are openly available in ClinVar (http://www.ncbi.nlm.nih.gov/clinvar (accessed on 18 May 2021)), Submission ID: SUB9674669 and SUB9674675.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Nanci A. Ten Cate’s Oral Histology. 8th ed. Mosby; St. Louis, MO, USA: 2013. pp. 1–13. [Google Scholar]
- 2.Goldberg M., Kulkarni A.B., Young M., Boskey A. Dentin structure composition and mineralization. Front. Biosci. 2011;E3:711–735. doi: 10.2741/e281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cao Y., Song M., Kim E., Shon W., Chugal N., Bogen G., Lin L., Kim R., Park N.-H., Kang M. Pulp-dentin Regeneration: Current State and Future Prospects. J. Dent. Res. 2015;94:1544–1551. doi: 10.1177/0022034515601658. [DOI] [PubMed] [Google Scholar]
- 4.Shields E.D., Bixler D., el-Kafrawy A.M. A proposed classification for heritable human dentine defects with a description of a new entity. Arch. Oral Biol. 1973;18:543–553. doi: 10.1016/0003-9969(73)90075-7. [DOI] [PubMed] [Google Scholar]
- 5.Barron M.J., McDonnell S.T., Mackie I., Dixon M.J. Hereditary dentine disorders: Dentinogenesis imperfecta and dentine dysplasia. Orphanet J. Rare Dis. 2008;3:31. doi: 10.1186/1750-1172-3-31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zhang X., Zhao J., Li C., Gao S., Qiu C., Liu P., Wu G., Qiang B., Lo W.H., Shen Y. DSPP mutation in dentinogenesis imperfecta Shields type II. Nat. Genet. 2001;27:151–152. doi: 10.1038/84765. [DOI] [PubMed] [Google Scholar]
- 7.Xiao S., Yu C., Chou X., Yuan W., Wang Y., Bu L., Fu G., Qian M., Yang J., Shi Y., et al. Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat. Genet. 2001;27:201–204. doi: 10.1038/84848. [DOI] [PubMed] [Google Scholar]
- 8.Kim J.-W., Hu J.C.-C., Lee J.-I., Moon S.-K., Kim Y.-J., Jang K.-T., Lee S.-H., Kim C.-C., Hahn S.-H., Simmer J.P. Mutational hot spot in the DSPP gene causing dentinogenesis imperfecta type II. Qual. Life Res. 2004;116:186–191. doi: 10.1007/s00439-004-1223-6. [DOI] [PubMed] [Google Scholar]
- 9.McKnight D.A., Hart P.S., Hart T.C., Hartsfield J.K., Wilson A., Wright J.T., Fisher L.W. A comprehensive analysis of normal variation and disease-causing mutations in the humanDSPPgene. Hum. Mutat. 2008;29:1392–1404. doi: 10.1002/humu.20783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Rajpar M.H., Koch M.J., Davies R.M., Mellody K.T., Kielty C.M., Dixon M.J. Mutation of the signal peptide region of the bicistronic gene DSPP affects translocation to the endoplasmic reticulum and results in defective dentine biomineralization. Hum. Mol. Genet. 2002;11:2559–2565. doi: 10.1093/hmg/11.21.2559. [DOI] [PubMed] [Google Scholar]
- 11.Kim J.-W., Simmer J.P. Hereditary Dentin Defects. J. Dent. Res. 2007;86:392–399. doi: 10.1177/154405910708600502. [DOI] [PubMed] [Google Scholar]
- 12.Kim J.-W., Nam S.-H., Jang K.-T., Lee S.-H., Kim C.-C., Hahn S.-H., Hu J.C.-C., Simmer J.P. A novel splice acceptor mutation in the DSPP gene causing dentinogenesis imperfecta type II. Qual. Life Res. 2004;115:248–254. doi: 10.1007/s00439-004-1143-5. [DOI] [PubMed] [Google Scholar]
- 13.Lee K.-E., Kang H.-Y., Lee S.-K., Yoo S.-H., Lee J.-C., Hwang Y.-H., Nam K.H., Kim J.-S., Park J.-C. Novel dentin phosphoprotein frameshift mutations in dentinogenesis imperfecta type II. Clin. Genet. 2011;79:378–384. doi: 10.1111/j.1399-0004.2010.01483.x. [DOI] [PubMed] [Google Scholar]
- 14.Kim Y., Kang J., Seymen F., Koruyucu M., Zhang H., Kasimoglu Y., Bayram M., Tuna-Ince E., Bayrak S., Tuloglu N., et al. Alteration of Exon Definition Causes Amelogenesis Imperfecta. J. Dent. Res. 2020;99:410–418. doi: 10.1177/0022034520901708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Li H., Durbin R. Fast and accurate long-read alignment with Burrows–Wheeler transform. Bioinformatics. 2010;26:589–595. doi: 10.1093/bioinformatics/btp698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Li H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics. 2011;27:2987–2993. doi: 10.1093/bioinformatics/btr509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Van Der Auwera G.A., Carneiro M.O., Hartl C., Poplin R., Del Angel G., Levy-Moonshine A., Jordan T., Shakir K., Roazen D., Thibault J., et al. From FastQ Data to High-Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline. Curr. Protoc. Bioinform. 2013;43:11.10.1–11.10.33. doi: 10.1002/0471250953.bi1110s43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wang K., Li M., Hakonarson H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164. doi: 10.1093/nar/gkq603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sillence D.O., Senn A., Danks D.M. Genetic heterogeneity in osteogenesis imperfecta. J. Med. Genet. 1979;16:101–116. doi: 10.1136/jmg.16.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Marini J.C., Forlino A., Bächinger H.P., Bishop N.J., Byers P.H., De Paepe A., Fassier F., Fratzl-Zelman N., Kozloff K.M., Krakow D., et al. Osteogenesis imperfecta. Nat. Rev. Dis. Primers. 2017;3:17052. doi: 10.1038/nrdp.2017.52. [DOI] [PubMed] [Google Scholar]
- 21.Rauch F., Lalic L., Roughley P., Glorieux F.H. Genotype–phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. Eur. J. Hum. Genet. 2010;18:642–647. doi: 10.1038/ejhg.2009.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Marini J.C., Forlino A., Cabral W.A., Barnes A.M., Antonio J.D.S., Milgrom S., Hyland J.C., Körkkö J., Prockop D.J., De Paepe A., et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: Regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum. Mutat. 2007;28:209–221. doi: 10.1002/humu.20429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lindahl K., Åström E., Rubin C.-J., Grigelioniene G., Malmgren B., Ljunggren Ö., Kindmark A. Genetic epidemiology, prevalence, and genotype–phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur. J. Hum. Genet. 2015;23:1042–1050. doi: 10.1038/ejhg.2015.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wang S.-K., Chan H.-C., Makovey I., Simmer J.P., Hu J.C.-C. Novel PAX9 and COL1A2 Missense Mutations Causing Tooth Agenesis and OI/DGI without Skeletal Abnormalities. PLoS ONE. 2012;7:e51533. doi: 10.1371/journal.pone.0051533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kantaputra P.N., Chinadet W., Intachai W., Ngamphiw C., Cairns J.R.K., Tongsima S. Isolated dentinogenesis imperfecta with glass-like enamel caused by COL1A2 mutation. Am. J. Med. Genet. Part A. 2018;176:2919–2923. doi: 10.1002/ajmg.a.40501. [DOI] [PubMed] [Google Scholar]
- 26.Subramanian S., Viswanathan V.K. StatPearls. StatPearls Publishing LLC.; Treasure Island, FL, USA: 2021. Osteogenesis Imperfecta. StatPearls Publishing Copyright © 2021. [PubMed] [Google Scholar]
- 27.Costantini A., Tournis S., Kämpe A., Ain N.U., Taylan F., Doulgeraki A., Mäkitie O. Autosomal Recessive Osteogenesis Imperfecta Caused by a Novel Homozygous COL1A2 Mutation. Calcif. Tissue Int. 2018;103:353–358. doi: 10.1007/s00223-018-0414-4. [DOI] [PubMed] [Google Scholar]
- 28.Udomchaiprasertkul W., Kuptanon C., Porntaveetus T., Shotelersuk V. A family with homozygous and heterozygous p.Gly337Ser mutations in COL1A2. Eur. J. Med. Genet. 2020;63:103896. doi: 10.1016/j.ejmg.2020.103896. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data presented in this study are openly available in ClinVar (http://www.ncbi.nlm.nih.gov/clinvar (accessed on 18 May 2021)), Submission ID: SUB9674669 and SUB9674675.